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Abstract
Introduction: Chronic pelvic pain in women is a complex condition, and physical 
therapy is recommended as part of a broader treatment approach. The objective of 
this study was to compare structured group-based multimodal physical therapy in a 
hospital setting (intervention group) with primary-care physical therapy (comparator 
group) for women with chronic pelvic pain.
Material and methods: Women aged 20-65 years with pelvic pain ≥6 months and re-
ferred for physical therapy were eligible. The primary outcome measure was change 
in the mean pelvic pain intensity from baseline to 12 months, measured using the 
numeric rating scale (0-10). Secondary outcomes were changes in scores of “worst” 
and “least” pain intensity, health-related quality of life, movement patterns, pain-
related fear of movements, anxiety and depression, subjective health complaints, 
sexual function, incontinence, and obstructed defecation. The differences between 
the groups regarding change in scores were analyzed using the independent t test and 
Mann-Whitney U test. Sensitivity analysis of the primary outcome was performed 
with a linear regression model adjusted for the baseline value. A P value <.05 was 
considered statistically significant.
Results: Of the 62 women included, 26 in the intervention group and 25 in the com-
parator group were available after 12 months for data collection and analysis. The 
difference between the groups for change in the mean pain intensity score was −1.2 
(95% CI −2.3 to −0.2; P = .027), favoring the intervention group. The intervention 
group showed greater improvements in respiratory patterns (mean difference 0.9; 
95% CI 0.2-1.6; P = .015) and pain-related fear of movements (mean difference 2.9; 
95% CI −5.5 to −0.3; P = .032), and no significant differences were observed between 
the groups for the other secondary outcomes.
Conclusions: Although the reduction in the mean pelvic pain intensity with group-
based multimodal physical therapy was significantly more than with primary-care 
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1  | INTRODUC TION
Chronic pelvic pain (CPP) in women is a complex condition, with 
a suggested worldwide prevalence of 6%-27%.1 CPP is defined 
as “chronic or persistent pain for at least 6 months, perceived 
in structures related to the pelvis, and often associated with 
negative cognitive, behavioral, sexual and emotional conse-
quences and symptoms of lower urinary tract, sexual, bowel, 
pelvic floor or gynecological dysfunction.”2 CPP is further sub-
divided into pain syndromes according to the location of the 
pain; however, in this study, we did not differentiate between 
these syndromes.2
Compared with the general female population, women with CPP 
report poorer total health, higher number of surgeries in the pel-
vic area, and more incidences of physical, sexual, and psychological 
abuse.1-3 Altered movement and respiratory patterns are observed,4 
and pain-related fear of movements are reportedly present.5 Long 
symptom duration and extensive investigations and treatments 
in different specialties are reported, often without satisfactory 
results.1
Clinical guidelines recommend a biopsychosocial approach in-
cluding physical therapy, pain education, and active patient partici-
pation.2 A systematic review of physical therapy treatment for CPP 
summarized that positive results can be achieved with single modal-
ities such as manual techniques and exercises, but the evidence is 
limited.6 Physical therapy focusing on body awareness and cognitive 
techniques has been highlighted as a promising therapy, and a future 
avenue for research in CPP.6
Group-based physical therapy is considered time saving and cost 
efficient; it can be as effective in reducing pain as individual treat-
ment and can provide social affinity for the participants.7 Despite 
this, no randomized controlled trials (RCTs) on group-based physical 
therapy for CPP have been identified.
A group-based multimodal physical therapy program that com-
bines body awareness therapy and patient education has been devel-
oped at the Pelvic Floor Center at the University Hospital of North 
Norway.8-10 Traditionally, women with CPP are referred for prima-
ry-care physical therapy after assessment by specialist doctors at 
hospitals.
The objective of this RCT was to compare group-based multi-
modal physical therapy (intervention group) with primary-care phys-
ical therapy (comparator group) in women with CPP. The primary 
hypothesis was that the intervention group will show greater re-
duction in the mean pain intensity than the comparator group after 
12 months.
2  | MATERIAL AND METHODS
This was a parallel group RCT with an allocation ratio of 1:1. 
Participants were recruited from the outpatient clinic at the Pelvic 
Floor Center at the University Hospital of North Norway, after as-
sessment by medical specialists. Eligibility and exclusion criteria are 
listed in Table 1.
The study intervention was based on the biopsychosocial model,11 
combined body awareness therapy,8,12 patient education,9,13 and 
cognitive approach of “acceptance and commitment therapy”10 in a 
group setting. There was a pre-planned schedule, with an initial 10-
day session followed by 2-day sessions after 3, 6, and 12 months. 
The aim was to reduce pain and improve daily function by challenging 
avoidance habits and providing new positive body experiences.8,12 
Detailed information about the intervention is shown in Supporting 
material, Table S1 (schedule) and Table S2 (TidiER checklist).
Women in the comparator group were referred to a physical 
therapist in primary health care with competence in women's 
health. The therapists received an information letter (Supporting 
material, Appendix S1), and they were asked to provide treatment 
according to their academic competence and in consultation with 
the woman. The deductibles of the physical therapy treatment 
were refunded.
The randomization database was administered by the Clinical 
Research Department at the hospital, and was available only for the 
primary researcher and the project leader. Randomization with alter-
nating block sizes of four and six was applied. A nurse at the Pelvic 
Floor Center provided the referrals to the treatment groups.
Baseline data were collected at the outpatient clinic at the time 
of inclusion before randomization, and all outcomes were collected 
again after 12 months. Information about pain intensities was also 
collected by mail at 3 and 6 months. Women who did not manage 
to travel to the hospital for the post-test for practical reasons were 
contacted by phone and mail. Two physical therapists (ASN and 
MFE) performed the baseline and follow-up tests.
Funding information
The Norwegian Fund for Post-Graduate 
Training in Physical Therapy and Northern 
Norway Regional Health Authority funded 
this study. The funding sources had no 
involvement in any stages of the study.
physical therapy, the difference in the change between the groups was less than ex-
pected and the clinical relevance is uncertain.
K E Y W O R D S
body awareness, chronic pelvic pain, group-based, patient education, physical therapy, 
randomized trial, women
Key Message
The reduction in the mean pain intensity with group-based 
multimodal physical therapy in a hospital setting was sig-
nificantly more than that with primary-care physical ther-
apy, but the difference in the change between the groups 
was less than expected and the clinical relevance is unclear.
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A semi-structured interview was used to collect demographic 
information (age, body mass index, smoking, children, civil status, 
education, and work status) and medical history (pain duration, pre-
vious surgeries, other diagnosis, and abuse exposure). At 12 months, 
the number of consultations and type of treatment were also regis-
tered. Supporting material, Appendices S2 and S3 show the inter-
view guides.
The primary outcome measure was change in mean pain inten-
sity from baseline to 12 months of follow up. The mean pelvic pain 
intensity during the previous 7 days was recorded on the validated 
11-point numeric rating scale (NRS, 0 = no pain, 10 = worst pain 
imaginable).14
The “worst” and “least” pain intensities during the last 7 days 
were registered as secondary outcome measures using the NRS.14
Movement patterns were assessed using the Standardized 
Mensendieck test, which evaluates performance of standing and 
sitting posture, active movements, gait, and respiration patterns ac-
cording to criteria based on functional anatomy.15 The test was video 
recorded before a blinded physical therapist scored the five domains 
on a scale of zero to seven (0 = least optimal, 7 = optimal) (Supporting 
material, Appendix S4). The Standardized Mensendieck test was val-
idated in a sample of Norwegian women with CPP.15
Pain-related fear of physical movement and activity was reg-
istered with the validated Tampa scale for Kinesiophobia.16 The 
women reported to what extent they agreed with the 13 different 
statements regarding associations between movement and possi-
ble injury or pain on a four-point Likert scale (1 = strongly disagree, 
4 = strongly agree), and the total was calculated in the score range 
of 13-52.
Health-related quality of life was measured using the EQ5D-5L 
questionnaire. An EQ5D-index and an EQ visual analogue scale 
(VAS) score were reported.17 The EQ5D-index ranges from −0.624 
to 1.000, with higher scores indicating better health, whereas the 
EQ VAS records total health on a VAS (0-100), where 100 is the best 
health you can imagine.17
Symptoms of anxiety and depression were recorded using 
the Hopkins Symptom checklist-25 (0-4, higher scores indicating 
more severe symptoms).18 Common somatic and psychological 
health complaints during the last 30 days were recorded using the 
Subjective Health Complaints questionnaire (0-87, higher scores in-
dicating more complaints).19 The presence and extent of urinary in-
continence (yes/no, scores 0-21),20 anal incontinence (yes/no, scores 
0-24),21 and obstructed defecation (yes/no, scores 0-25)22 were re-
corded using validated questionnaires. Sexual function was mapped 
with questions regarding whether the women were sexually active 
(yes/no), had reduced/lack of sexual desire (yes/no), and/or had 
presence of pain during intercourse (yes/no). Pain intensity during 
intercourse was registered using an NRS (score 0-10).23,24
2.1 | Statistical analyses
The sample size was calculated based on the results from an RCT 
conducted on women with CPP that applied an intervention similar 
to the one in this study, though it was individually delivered. The 
aforementioned study showed a change of 2.2 on the NRS for mean 
pain intensity between the groups after 3 months,25 which indicated 
a difference of one standard deviation in the change. Based on these 
assumptions, the effect size was estimated as “1”. With a significance 
level of 0.05, a power of 90%, and an estimated dropout rate of 30%, 
33 women should be included in each group.
Descriptive statistics were presented as mean and standard de-
viation or median and interquartile range for the continuous vari-
ables, and frequencies and percentages for the categorical variables. 
In case of missing data on sub-items of the secondary outcome mea-
sures, averages of the available responses were used.26
Statistical analyses followed the intention-to-treat approach. 
For continuous data, independent samples t test or Mann-Whitney 
U test was used for primary analyses of group differences in the 
change in the groups from baseline to 12 months. The assumptions 
for parametric tests of normal distribution of residuals and equal-
ity of variances were checked before analyzing the data. For the 
categorical variables, changes in the number of women reporting 
problems were described. Sensitivity analysis of the primary out-
come was performed with a linear regression model adjusted for the 
baseline value. The significance level was set at P = .05. Statistical 
analyses were conducted using the Statistical Package for the Social 
Sciences, version 25 for Macintosh (IBM SPSS Statistics).27
2.2 | Ethical approval
This study was conducted in accordance with the principles of the 
Declaration of Helsinki. Written and oral study information was 
provided to the participants, and the informed consent forms were 
signed. The study was approved by the Regional Committee for 
TA B L E  1   Eligibility criteria
Inclusion criteria Exclusion criteria
Norwegian-
speaking women
Malignancy and conditions requiring special 
medical attention
Age 20-65 years Pregnancy at the time of inclusion or 
childbirth during the previous 12 months




participate in a 
group intervention
Serious psychiatric diagnosis
Previous treatment by the physical 
therapists involved in the intervention
Intra-abdominal or pelvic surgery within the 
last 6 months
Botulinum toxin injections in the pelvic area 
in the last 4 months
aEngeler et al, European Association of Urology Guidelines on Chronic 
Pelvic Pain 2017. https://uroweb.org/guide line/chron ic-pelvi c-pain/. 
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Medical and Health Research Ethics North (18.09.2014 2014/1398) 
and by the Institutional Review Board at the University Hospital 
of North Norway (0444/24.02.2015). The trial was registered at 
clinicaltrials.gov (NCT02356796, 5 February 2015) and reported 
in accordance with the CONSORT statement (Supporting material, 
Table S3).28
2.3 | Deviations from registered trial protocol
Regrettably, the registration of the primary outcome at clinicaltrials.
gov was misleading, including mean, least, and worst recorded pain 
intensities at three different time-points. Some secondary outcomes 
were also registered as measured at different time-points. However, 
the objective of the trial was to analyze changes from baseline to 
12 months. Additionally, the sample size calculation was 46 and not 
50, as registered at clinicaltrials.gov.
3  | RESULTS
Sixty-two women were randomly assigned to the intervention group 
(n = 30) and the comparator group (n = 32) between March 2015 
and November 2016. Data collection was completed in January 
2017, with the data of 26 and 25 women available for the 12-month 
analyses from the intervention and comparator groups, respectively. 
Participant selection flow, including reasons for dropout, is shown 
in Figure 1. Table 2 provides the baseline characteristics of the 
participants in both groups. A detailed description of the sample was 
provided in a previously published paper.24
The majority of women in the intervention group attended all 
the sessions. One woman attended only for the first 10-day ses-
sion, and seven attended 12-14 days of the total 16 treatment days 
(median 16, interquartile range 2). In the comparator group the me-
dian number of physical therapy consultations was 14 (interquar-
tile range 29). One-third of the comparator group women reported 
that they had received pelvic floor muscle training combined with 
general exercises and/or relaxation exercises, 50% had received 
soft-tissue treatment alone or in combination with exercises, and 
50% reported that dialogue with the therapist was a part of the 
treatment.
For the primary outcome the group-difference in change was 
−1.2 (95% CI −2.3 to −0.2, P = .027) (Table 3). In the intervention 
group, 19 women reported improvement, whereas four women re-
ported no change and three reported worsening in mean pain inten-
sity as compared with the 17, 3, and 5 women, respectively, in the 
comparator group. Except for a lack of reduction in pain, no adverse 
effects were registered.
Regarding the secondary outcomes, statistically significant 
differences were detected only in the respiratory patterns and 
pain-related fear of movements (Tables 4 and 5). Sixteen women 
(62% and 64% in the intervention and comparator groups, respec-
tively) from both groups reported being sexually active both at 
baseline and 12 months. Among those, 12 (86%, two missing) in 
the intervention group and 12 (75%) in the comparator group re-
ported reduced sexual desire at baseline. After 12 months, eight 
F I G U R E  1   Participant flow including reasons for dropout
Assessed for eligibility
(n = 108)
Randomized (n = 62)
Allocated to the study intervention (n = 32)
Received allocated intervention (n = 28)
Did not receive allocated intervention (n = 4)
Excluded before inclusion
(n = 46)
- Not meeting inclusion 
criteria (n = 15)















Allocated to comparator treatment (n = 30)
Received allocated intervention (n = 29)
Did not receive allocated intervention (n = 1)
Analyzed at 12 months (n = 26)
Excluded from analysis (n =0)
Discontinued intervention (n = 3)
Lost to follow-up (n = 6)
Discontinued intervention (n=1) 
Lost to follow-up (n = 3)
Analyzed (n = 25)
Excluded from analysis due to missing 12-
months data (n = 2)
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Intervention group (n = 32)
Comparator group 
(n = 30)
Mean, n or 
median
SD, % or 
IQR




Age, years 39.7 10.9 36.2 13.8
BMI, kg/m2 26.7 5.8 26.9 5.6
Smoking, yes 8 25 6 20
Premenopausal, yes 23 77 22 76
Children, number 2.0 1.5 1.3 1.2
Married or cohabiting, yes 27 84 21 70
Education, highera , yes 13 41 15 50
Working or student, yes 16 50 18 60
Currently on sick leave, yes 5 16 7 23
Sick leave >12 weeks last 
year, yes
11 34 7 23
Receiving social benefits, yes 12 38 11 37
Previous surgery (lower 
abdomen or pelvis), yes
22 71 20 67
Previous surgeries, number 1.5 0-3 1.0 0-2
Previous diagnosis in the pelvic area, yes
Ovarian cysts 13 41 9 30
Urinary tract infections, 
repeated
9 28 7 23
OASIS 4 13 4 13
Endometriosis 3 9 6 20
Exposed to abuse (physical, 
psychological or sexual), yes
13 41 18 60
Duration of pelvic pain, years
1-2 4 12.5 4 13.3
2-4 7 21.9 4 13.3
4-6 8 25 4 13.3
6-10 1 3.1 4 13.3
>10 12 37.5 14 46.7
Mean pelvic pain intensity, 
NRS
4.4 2.0 4.5 2.8
Abbreviations: BMI, body mass index; IQR, interquartile range; NRS, numeric rating scale; OASIS, 
obstetric anal sphincter injuries; SD, standard deviation.
aCompleted ≥1 year at the University College or University. 
TA B L E  2   Baseline characteristics of 
the participants in the intervention group 
and comparator group





Change baseline to 
12 months
Difference in change between the groups
Primary analysis Sensitivity analysisa 
Mean SD Mean SD Mean 95% CI Mean 95% CI P Mean 95% CI P
Intervention 
group (n = 26)
4.7 2.0 3.0 2.4 −1.8 −2.6 to −1.0 −1.2 −2.3 to −0.2 .027 −1.2 −2.3 to −0.1 .030
Comparator 
group (n = 25)
4.5 2.8 4.0 2.9 −0.5 −1.3 to 0.3
Abbreviations: NRS, numeric rating scale; SD, standard deviation.
aAdjusted for baseline values of mean pain intensity. 
     |  1325NYGAARD et Al.
(50%) in the intervention group and 10 (63%) in the comparator 
reported reduced sexual desire. At baseline, nine (75%, four miss-
ing) in the intervention group and 11 (73%, one missing) in the 
comparator group reported painful intercourse. After 12 months, 
six (38%) women in the intervention group and 10 (63%) in the 
comparator group reported painful intercourse. Pain intensity 
during intercourse was reduced by 3.0 on the NRS from baseline 
to 12 months in the intervention group compared with a reduc-
tion of 1.1 reduction in the comparator group (difference in groups 
−1.9; 95% CI −5.6 to 2.0; P = .326). There were no differences in 
the total scores for incontinence or obstructed defecation be-
tween the groups (Table 5).
4  | DISCUSSION
To our knowledge, this is the first RCT comparing a group-based 
treatment consisting of body awareness therapy, patient educa-
tion, and cognitive techniques with primary-care physical therapy 
for women with CPP. We found a smaller than expected difference 
between the groups with respect to reduction in mean pelvic pain 
intensity after 12 months, but the difference was statistically sig-
nificant. The intervention group showed additional improvements 
in the respiratory patterns and in pain-related fear of movements. 
However, changes in “worst” and “least” pain intensities, health-
related quality of life, other movement patterns, symptoms of anxi-
ety and depression, subjective health complaints, sexual function, 
incontinence, and obstructed defecation were not statistically dif-
ferent between the groups.
The strengths of this study are the RCT design, validated out-
come measures, and the use of a definition and intervention in 
accordance with the clinical guidelines.2 The primary outcome 
measure was defined as change in pain intensity, which reflects just 
one aspect of CPP,1 and other end points might be better suited to 
this type of intervention. Comparing the study intervention with 
non-standardized physical therapy can be considered a limitation 
because of the heterogeneous treatment. However, there is no 
consensus on a standardized physical therapy approach in CPP,6 
and comparing the intervention with the “usual treatment” offered 
to these women provides real-world clinical data. Furthermore, 
the lack of blinding of the data collectors and patients is a limita-
tion, and there might be a selection bias because one-third of the 
eligible women declined to participate. Reasons for not attending 
were economic concerns, and practical or emotional challenges of 
staying away from home. The dropout rate was 18%, which in-
fluences the generalizability of our findings. These results apply 
only to women with characteristics similar to the 51 participants 
included in the 12-month analyses of this study. The limited num-
ber of participants and the low power of the study mean that the 
results of all the secondary outcomes should be interpreted with 
caution.
The difference between the groups regarding the change in 
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TA B L E  5   Differences between the intervention (n = 26) and comparator (n = 25) groups regarding the changes in the secondary 


















IQR Mean 95% CI P
Worst pain, NRS 0-10
Intervention group n = 24 6.8 2.4 4.0 3.3 −2.7 3.5 −1.4 −0.4 to 3.1 .117
Comparator group, n = 25 6.3 2.6 5.0 3.1 −1.3 2.5
Least pain, NRS 0-10
Intervention group n = 21 2.2 2.0 1.7 2.0 −1.7 2.1 0.3 −0.9 to 1.4 .651
Comparator group n = 22 2.2 2.5 1.5 1.6 0.5 1.4
Movement patterns, SMT 0-7
Posture
Intervention group n = 24 4.8 0.7 5.0 0.5 0.2 0.7 0.3 −0.1 to 0.7 .104
Comparator group, n = 22 4.8 0.6 4.8 0.7 −0.1 0.7
Active movements
Intervention group n = 24 4.2 1.2 5.0 0.7 0.7 1.1 0.1 −0.5 to 0.8 0.637
Comparator group, n = 22 4.0 1.1 4.7 1.0 0.6 0.9
Sitting posture
Intervention group n = 23 5.1 1.3 5.5 1.1 0.4 1.0 0.1 −0.7 to 0.6 .838
Comparator group, n = 22 4.9 1.2 5.2 1.0 0.3 1.2
Gait
Intervention group n = 22 4.5 1.2 5.1 1.0 0.5 0.8 0.0 −0.6 to 0.6 .881
Comparator group, n = 22 4.2 1.3 4.7 1.4 0.5 1.1
Respiration
Intervention group n = 23 4.1 1.3 5.0 1.2 0.8 1.4 0.9 0.2-1.6 .015
Comparator group, n = 21 3.9 1.2 4.1 1.0 −0.1 0.9
Pain-related fear of movements, TSK 13-52
Intervention group, n = 24 24.4 4.8 19.4 4.3 −5.0 3.7 −2.9 −5.5 to −0.3 .032
Comparator group, n = 25 23.0 6.3 20.8 5.9 −2.1 5.3
Health-related quality of life, EQ5D-5L
EQ5D index value, −0.624 to 1.000
Intervention group, n = 26 0.67 0.14 0.72 0.19 0.05 0.16 −0.01 −0.09 to 
0.07
.814
Comparator group, n = 25 0.64 0.19 0.70 0.21 0.06 0.13
EQ-VAS, 0-100
Intervention group, n = 24 58.0 19.1 62.1 20.3 4.1 22.4 −2.0 −14.9 to 
10.9
.757
Comparator group, n = 25 58.2 22.5 64.2 18.1 6.1 22.5
Symptoms of anxiety and depression, HSCL-25 0-4
Intervention group, n = 21 1.83 0.45 1.52 0.38 −0.30 0.46 −0.15 −0.41 to 
0.11
.241
Comparator group, n = 22 1.78 0.51 1.64 0.54 −0.15 0.39
Subjective Health Complaints, SHC 0-87
Intervention group, n = 22 20.9 11.6 22.4 12.2 1.5 16.8 7.2 −2.6 to 17.1 .146
Comparator group, n = 25 20.3 11.6 14.6 11.2 −5.7 16.7
Urinary incontinence, ICIQ-UI, 0-21 (median, IQR)
Intervention group, n = 23 4.0 8.0 3.0 6.0 0.0 3.0 .370a 
Comparator group, n = 25 3.0 4.5 3.0 6.5 0.4 1.5
(Continues)
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previous RCT by Haugstad et al25 The clinical relevance of a differ-
ence of only 1.2 must be questioned, despite its statistical signifi-
cance. Approximately one quarter of the women in the intervention 
group reported unchanged or worse mean pain intensity scores, 
which contrasts with results by Haugstad et al, where only one of 
the 19 women in the group receiving physical therapy combined 
with cognitive techniques reported unchanged pain intensity.25 This 
possibly reflects the differences between the study samples, but it 
could also indicate a need for refining both the study intervention 
and selection criteria. Some women with CPP may respond better to 
individual treatment. Group-based treatment as well as treatments 
aiming to change personal habits can be challenging for some pa-
tients.7 Future studies should investigate predictors for different 
treatment approaches.29
A recently published RCT on 49 women with CPP by Ariza-
Mateos et al compared a combination of manual physical therapy, 
exercises, and pain education with manual physical therapy alone.30 
The primary outcome was fear-avoidance behavior, which showed 
significantly more improvement in the combined treatment group. 
The difference between the groups regarding pain reduction was 
1.1, which was similar to our result. The larger difference between 
the groups in the study by Haugstad et al could be because the com-
bined physical therapy treatment was compared with standard gy-
necological care only, and the participants had higher baseline pain 
scores.25
The greatest reduction in mean pain intensity in the interven-
tion group was observed between 6 and 12 months. This sug-
gests that the long duration of the treatment is important, which 
is in accordance with theories of behavioral change that emphasize 
that it takes time to integrate new experiences and obtain lasting 
changes.31 A subject for future studies would be to perform another 
follow up 12 months after the end of treatment.
Reduced pain intensity reflects only one aspect of posi-
tive changes for women with the complex condition of CPP, and 
selection of appropriate end points is challenging.1,2 The greater 
improvements in respiratory patterns and pain-related fear of 
movement in the intervention group corroborate with the previ-
ous results presented by Haugstad et al25 and Ariza-Mateos et al.30 
Improved respiratory patterns, in terms of increased deep respi-
ration with abdominal expansion, may be related to the relaxation 
techniques and body awareness therapy applied in the study inter-
vention, so may be related to pain reduction. Pain-related fear of 
movements is emphasized as a key mechanism for the development 
and maintenance of chronic pain, and hence it is a relevant outcome 
to include.32
For health-related quality of life, we observed that the base-
line scores for EQ5D-5L were low compared with the population 
scores.33 No significant differences in change were found for ei-
ther the EQ5D-index or EQ-VAS scores. In future studies, a symp-
tom-specific measure of health-related quality of life might add 
more information, because EQ5D-5L may not be sufficiently re-
sponsive to detect changes.34 Differences between the groups for 
symptoms of anxiety and depression were not observed. The out-
come measures for sexual, urological, and bowel functions were 
included according to the CPP definition,2 and no group differ-
ences were detected.
Studying complex interventions for a complex condition such as 
CPP has several challenges. The optimal treatment is still uncertain, 
and more research is needed to refine the multimodal interven-
tion, probably by tailoring the treatment for different subgroups of 
women with CPP.
5  | CONCLUSION
The reduction in the mean pelvic pain with group-based multimodal 
physical therapy was significantly more than that of primary-care 


















IQR Mean 95% CI P
Anal incontinence, St. Marks 0-24 (median, IQR)
Intervention group, n = 24 0.0 2.0 0.0 2.0 0.0 0.0 .120a 
Comparator group, n = 25 0.0 7.5 0.0 4.0 0.0 2.0
Obstructed defecation, ODS 0-25 (median, IQR)
Intervention group, n = 25 5.0 8.0 6.0 7.0 −2.0 4.0 .337a 
Comparator group, n = 25 7.0 8.0 6.0 7.0 0.0 3.5
Note: Bold values are statistically significant (P < .05).
Abbreviations: HSCL-25, Hopkins Symptom Check List; ICIQ-UI; ICIQ -Urinary Incontinence Short Form; IQR, interquartile range; NRS, numeric 
rating scale; ODS, obstructed defecation score; SD, standard deviation; SHC, Subjective Health Complaints questionnaire; SMT, Standardized 
Mensendieck Test; TSK-13, Tampa Scale of Kinesiophobia.
aMann-Whitney U test. 
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was not found, and we cannot conclude that a group-based inter-
vention including body awareness therapy, patient education, and 
cognitive techniques is clinically better than primary-care physical 
therapy for women with CPP.
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